Defining On-Treatment Remission in Plaque Psoriasis

Through a Delphi consensus process, on-treatment remission for plaque psoriasis was defined as patients maintaining a BSA involvement of 0% or IGA of 0 for at least 6 months while on treatment. This clear and standardized benchmark is applicable to both research and practice settings.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2025-06-18
DOI
https://doi.org/10.1001/jamadermatol.2025.1625
Citations
4
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
3.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Defining On-Treatment Remission in Plaque Psoriasis

Steven R. Feldman, Ronald Prussick, April Armstrong, Charlotte Read et al.
4 citations
JAMA Dermatology
Psoriasis: Treatment and Pathogenesis
3.19
article

Defining On-Treatment Remission in Plaque Psoriasis

Steven R. Feldman, Ronald Prussick, April Armstrong, Charlotte Read, Yasmin Gutierrez, G. Michael Lewitt, Stephanie T. Le, Deepak Balak, Cheryl F. Rosen, Joel M. Gelfand, Emanual Maverakis, Tina Bhutani, Gil Yosipovitch, José U. Scher, Lourdes M. Pérez-Chada, Robert E. Kalb, Steven Fakharzadeh, Samuel Hwang, Joseph Frank Merola, Dafna D. Gladman, George Han, Paul S. Yamauchi, Evan Siegel, Alyssa Roberts, Leon Kircik, Richard G. Langley, Jason E. Hawkes, George Gondo, Wilson Liao, Guy S. Eakin, Nicole Johnsen, Lawrence J. Green, Soumya M. Reddy, Kristina Callis Duffin, Jeffrey M Weinberg, Brad Glick, Mark Lebwohl, Elizabeth B. Wallace, Andrew Blauvelt
article en
4 citations

Abstract

Through a Delphi consensus process, on-treatment remission for plaque psoriasis was defined as patients maintaining a BSA involvement of 0% or IGA of 0 for at least 6 months while on treatment. This clear and standardized benchmark is applicable to both research and practice settings.

JAMA DermatologyVol. 161(8)
University of California, Riverside (US), University of Southern California (US), University of Hawaiʻi at Mānoa (US), Brigham and Women's Hospital (US), Dalhousie University (CA), University Health Network (CA), Johnson & Johnson (United States) (US), Harvard University (US), University of Miami (US), University of California, Los Angeles (US), University of California, San Francisco (US), Georgetown University (US), University of Toronto (CA), Rosalind Franklin University of Medicine and Science (US), George Washington University (US), University of Utah (US), Toronto Western Hospital (CA), Leiden University Medical Center (NL), Palm Springs General Hospital (US), NYU Langone Health (US), National Psoriasis Foundation (US), ASIS Foundation (US), Southwestern Medical Center (US), Maryland Department of Natural Resources (US), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Arthritis and Rheumatism Associates (US), Denova Research (US), Illinois Public Health Institute (US), Oregon Medical Research Center (US), DermResearch (United States) (US), Synergy Health (US), Janssen (United States) (US), Krembil Research Institute, Indiana University School of Medicine, Wake Forest University (US), Indiana University – Purdue University Indianapolis (US), New York University (US), University at Buffalo, State University of New York (US), University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), Icahn School of Medicine at Mount Sinai (US)
Partnerships for the goals
Openalex Percentile: Top 8%
Psoriasis: Treatment and Pathogenesis
3.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.